Larimar Therapeutics
LRMR
LRMR
104 hedge funds and large institutions have $483M invested in Larimar Therapeutics in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
43% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 23
9.72% more ownership
Funds ownership: 89.99% → 99.71% (+9.7%)
Holders
104
Holding in Top 10
3
Calls
$9.71M
Puts
$1.89M
Top Buyers
| 1 | +$47.1M | |
| 2 | +$33.4M | |
| 3 | +$25.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$10.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.48M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$3.5M | |
| 3 | -$1.28M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$913K |
| 5 |
Morgan Stanley
New York
|
-$508K |